A shareholder derivative suit is structurally unusual because the plaintiff shareholder is not suing for their own injury -- they are suing on behalf of the corporation itself, asserting a claim that legally belongs to the company against the very directors and officers who run it. That structure creates a threshold problem before the merits are ever reached: since the board normally controls whether the corporation sues anyone, a derivative plaintiff must first make a demand on the board to pursue the claim, or plead with particularity why demand would be futile because a majority of the board faces a substantial likelihood of personal liability or lacks independence from the wrongdoers. Delaware's Aronson and Rales tests, and their equivalents in other states, control this futility analysis and function as the case's real gatekeeper, since a large share of derivative suits are dismissed at the pleading stage without ever reaching discovery on the underlying misconduct. Once past demand, the business judgment rule presumes that directors acted on an informed basis, in good faith, and in the corporation's best interest, and the plaintiff bears the burden of rebutting that presumption.

Boards facing a derivative suit that survives demand often respond by forming a Special Litigation Committee of independent directors to investigate the claims and recommend whether the suit should continue, be settled, or be dismissed, and courts give that recommendation real but not unlimited deference depending on the committee's independence and the thoroughness of its investigation. The economics of these cases cut against the nominal plaintiff in a way most litigation does not: any monetary recovery flows to the corporate treasury, not to the shareholder who brought the suit, so the shareholder's practical stake is often limited to the attorney's fee award that follows a successful result, which shapes both which cases get brought and how they get resolved. Settlements frequently take the form of corporate governance reforms -- new board committees, revised related-party transaction approval processes, expanded director independence requirements -- paired with a fee award, rather than a cash payment to the company, particularly where the underlying harm is hard to quantify or the business judgment rule makes a damages verdict unlikely.

Demand futility is the case's real gatekeeper: because a large share of derivative suits are dismissed at the pleading stage under Aronson or Rales before any discovery on the underlying misconduct, plaintiffs' counsel invest heavily in pleading particularized facts about board independence and potential liability long before valuing the claim itself. A Special Litigation Committee can reset the entire trajectory once a suit survives demand, since a court that finds the committee independent and its investigation thorough will often defer to its recommendation to dismiss or settle. Because any monetary recovery flows to the corporate treasury rather than to the shareholder plaintiff, settlements skew toward governance reforms paired with a fee award, and the practical economic stake for the plaintiff's side is usually the fee, not the judgment.